Search


Enanta’s CEO discusses RSV and Covid drug development on its earnings day
Jay Luly goes in depth on antiviral drug development and discusses his company’s efforts to try to develop the first therapeutic for RSV.
Aug 7, 2023
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.